| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.71B | +13.2% |
| R&D Expense | $17.2M | +50.9% |
| SG&A Expense | $88.4M | +37.6% |
| Operating Income | $94.2M | +771.7% |
| Pre-tax Income | $98.0M | +367.7% |
| Income Tax | $46.0M | +3.9% |
| Net Income | $51.9M | +322.3% |
| EPS (Basic) | $0.45 | +314.3% |
| EPS (Diluted) | $0.45 | +314.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $183.0M | +20.6% |
| Accounts Receivable | $517.6M | +10.3% |
| Inventory | $159.0M | +11.0% |
| Current Assets | $964.0M | +13.2% |
| Total Assets | $2.33B | +15.9% |
| Current Liabilities | $484.4M | -0.9% |
| Long-term Debt | $121.1M | +505.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $169.5M | +22.5% |
| Capital Expenditures | $143.6M | +17.6% |
| Investing Cash Flow | -$165.1M | -11.4% |
| Financing Cash Flow | $29.6M | +159.9% |
| Free Cash Flow | $25.9M | +59.9% |
| Total Liabilities |
| $842.1M |
| +17.4% |
| Stockholders' Equity | $1.49B | +15.1% |